Skip to content

PRQR

ProQR Therapeutics N.V.

NASDAQ · Healthcare · Biotechnology · NL

$2.07
−0.96%
Ask drillr
5
Insider buys (3m)
0
Insider sells (3m)
$1.3M
Net value (3m)
+39.7%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 3, 2026de Boer Daniel Anton · director, officer: Chief Executive OfficerPurchase200,000$1.77
Jul 21, 2026Filius Bart · directorPurchase150,000$1.72
Jul 13, 2026de Boer Daniel Anton · director, officer: Chief Executive OfficerPurchase150,000$1.74
Jul 8, 2026de Boer Daniel Anton · director, officer: Chief Executive OfficerPurchase150,000$1.59
Jun 30, 2026Hinsch Gylvin Lykke · directorA-Award14,595$1.42
Jun 30, 2026Filius Bart · directorPurchase150,000$1.54
Institutional positioning

13F filings over the trailing two quarters

New 9Increased 16Reduced 17Sold out 69
FilerActionSharesFiled
ADAGE CAPITAL PARTNERS GP, L.L.C.Unchanged6,253,467May 15, 2026
PRIVIUM FUND MANAGEMENT B.V.Increased5,467,149May 5, 2026
ABRDN PLCIncreased3,316,965Apr 29, 2026
AFFINITY ASSET ADVISORS, LLCUnchanged2,454,278May 14, 2026
SIO CAPITAL MANAGEMENT, LLCReduced1,954,715May 14, 2026
DAFNA CAPITAL MANAGEMENT LLCUnchanged1,567,561May 15, 2026
KYNAM CAPITAL MANAGEMENT, LPUnchanged1,566,317May 15, 2026
IKARIAN CAPITAL, LLCUnchanged1,492,229May 15, 2026
MORGAN STANLEYReduced1,299,775May 15, 2026
PLATINUM INVESTMENT MANAGEMENT LTDUnchanged1,235,514May 14, 2026
CITADEL ADVISORS LLCIncreased1,184,314Sep 2, 2026
TWO SIGMA INVESTMENTS, LPIncreased918,857May 15, 2026
POINT72 ASSET MANAGEMENT, L.P.Reduced755,842May 15, 2026
CITADEL ADVISORS LLCIncreased703,323May 15, 2026
MACQUARIE MANAGEMENT HOLDINGS, INC.Unchanged620,000May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 3, 2026